This reduction is accompanied by an upregulation in the activity of ECM proteases such as tPA and MMP-9 and a modulation in the expression of ECM proteases and inhibitors such as Adamts4 and Timp1. Similar results were seen in brain tissue from stroke patients. The gene discussed is ADAMTS4; the disease is stroke disorder.